Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-7643-05 Anamorelin in Cancer Cachexia (Gastrointestinal Cancers)
jRCT2080223371Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of anamorelin in cancer anorexia-cachexia syndrome (CACS), colorectal cancer (CRC), gastric cancer (GC) and 1 more, sponsored by Ono Pharmaceutical. Started Nov 2016; status: completed.
02
Drugs
anamorelin
03
Conditions
cancer anorexia-cachexia syndrome (CACS)colorectal cancer (CRC)gastric cancer (GC)pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT2080223371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223371.